Skip to main content

Table 4 Demographic and clinical characteristics of participants in the trimester 3 replication phase

From: A longitudinal epigenome-wide association study of preeclamptic and normotensive pregnancy

Characteristics

Validation sample

Independent sample

Combined sample

Matched variables

Preeclampsia cases (n= 25)

Normotensive controls (n= 28)

p

Preeclampsia cases (n= 64)

Normotensive controls (n= 50)

p

Preeclampsia cases (n= 89)

Normotensive controls (n= 78)

p

Race, n (%)

 Black

18 (72.0%)

21 (75.0%)

NA*

7 (10.9%)

5 (10.0%)

NA*

25 (28.1%)

26 (33.3%)

NA*

 White

7 (28.0%)

7 (25.0%)

57 (89.1%)

45 (90.0%)

64 (71.9%)

52 (66.7%)

Pre-pregnancy BMI, mean kg/m2 (SD)

32.5 (7.0)

33.7 (7.5)

25.5 (5.0)

24.7 (4.7)

27.5 (6.4)

28.0 (7.2)

Gestational age at sample collection, mean weeks (SD)

      

 Trimester 3

37.0 (2.5)

37.4 (2.5)

36.7 (3.3)

38.1 (2.2)

36.8 (3.1)

37.9 (2.3)

Unmatched variables

Preeclampsia cases (n= 25)

Normotensive controls (n= 28)

p**

Preeclampsia cases (n= 64)

Normotensive controls (n= 50)

p**

Preeclampsia cases (n= 89)

Normotensive controls (n= 78)

p**

Parity, n (%)

 Nulliparous (Yes)

18 (72.0%)

24 (85.7%)

0.10

52 (81.3%)

38 (76.0%)

0.48

70 (78.7%)

62 (79.5%)

0.89

  (No)

7 (28.0%)

4 (14.3%)

 

12 (18.7%)

12 (24.0%)

 

19 (21.3%)

16 (20.5%)

 

Maternal age at birth, mean years (SD)

24.2 (5.2)

23.7 (4.2)

0.70

27.2 (6.7)

28.0 (5.8)

0.53

26.4 (6.5)

26.4 (5.7)

0.96

Gestational age at delivery, mean weeks (SD)

37.3 (2.5)

39.5 (1.3)

6.16×10-4

36.8 (3.3)

38.8 (1.2)

8.46×10-7

36.9 (3.1)

39.1 (1.3)

5.09×10-9

Blood pressure <20 weeks, mean mmHg (SD)

 Systolic

113.0 (7.7)

111.5 (8.9)

0.40

114.2 (9.4)

114.7 (8.4)

0.78

113.9 (8.9)

113.5 (8.7)

0.80

 Missing

0

0

/

3

1

/

3

1

/

 Diastolic

70.0 (5.9)

66.8 (6.1)

0.05

70.2 (7.4)

69.7 (5.3)

0.71

70.1 (7.0)

68.7 (5.7)

0.15

 Missing

0

0

/

3

1

/

3

1

/

Blood pressure prior to delivery, mean mmHg (SD)

 Systolic

148.8 (7.1)

124.5 (6.1)

1.02×10-12

155.5 (15.1)

120.8 (11.9)

2.43×10-19

153.6 (13.7)

122.1 (10.3)

9.82×10-28

 Diastolic

91.2 (8.3)

71.1 (6.2)

3.54×10-9

92.6 (8.8)

73.8 (7.3)

5.83×10-18

92.2 (8.6)

72.8 (7.0)

3.30×10-26

  1. Validation sample, all trimester 3 samples from the discovery phase were sent for validation with the pyrosequencing platform; Independent sample, trimester 3 samples from test sample completely independent of the discovery phase; Combined sample, pooled validation and independent samples
  2. *Variables matched based on self-identified race, pre-pregnancy BMI, and gestational age at sample collection (± 2 weeks when possible) so p values are not reported
  3. **P values from the partially overlapping samples t test for continuous variables and partially overlapping samples z test for dichotomous variable